glo1 semaglutide GLP-1s for Weight Loss: What You Need to Know Semaglutide | GLP-1R Ligand |

During perimenopause, your levels of estrogen and progesterone begin to naturally decline

Medical Writing/Editorial Assistance The authors acknowledge Festina Lente for providing methodological support, medical writing, and editorial assistance

Your provider should review your specific cardiovascular baseline before initiating therapy to set appropriate expectations and monitoring protocols

NHS access requires BMI 35 kg/m (or 32.5 kg/m for specific ethnic groups) with weight-related comorbidities and previous lifestyle modification attempts

Cons: Side Effects: Can cause nausea, gastrointestinal discomfort and headaches in some individuals